John M. Burke, MD, turns to ChatGPT to uncover what artificial intelligence may do for hematologists/oncologists.
Artificial intelligence (AI) is all the rage. Although AI has been a part of our lives for a long time, the release of the online chatbot ChatGPT by the company OpenAI on November 30, 2022, has ushered in a new era of enthusiasm about the potential for AI to improve our lives. If you haven’t tried ChatGPT yet, you’re probably one of the few. Based on current estimates, the ChatGPT website has approximately 25 million visitors daily. Microsoft has invested $10 billion in OpenAI. Google has announced that it will be incorporating conversational AI into its search engine. And in medicine, the New England Journal of Medicine has announced that it is planning a new online journal called NEJM AI “to identify and evaluate state-of-the-art applications of artificial intelligence to clinical medicine.”
What could AI do for physicians in general and hematologists/oncologists in particular? To answer that question, I turned to ChatGPT itself.
First, AI could help radiologists read scans better and reduce the rates of false-positive and false-negative results, thereby detecting malignant tumors on imaging studies more accurately. Second, in the era of targeted therapies, AI could identify biomarkers and help physicians choose correct treatments.
Third, AI could improve remote monitoring of patients by interpreting data from wearable devices. This feature would be particularly useful as we start to use bispecific antibodies and monitor patients’ vital signs carefully for signs of cytokine release syndrome, but it would also help patients who are receiving conventional chemotherapy.
Fourth, AI-powered robots could assist surgeons performing operations, enabling a greater degree of precision and accuracy. Fifth, chatbots could listen to a visit between physician and patient and write a note summarizing the content.
Sixth, chatbots can already help us think through diagnostic challenges presented by patients. For example, I asked ChatGPT what diagnoses I should consider for a patient reporting blisters on the back of her hands. It listed a differential diagnosis of 6 conditions (although it failed to mention porphyria cutea tarda, which is what I was thinking).
I’m sure there are countless more examples of tasks that AI could help physicians with. In fact, this entire article about AI in oncology could have been written for me in approximately 10 seconds by ChatGPT. I know this because I tried it, and it worked. But I didn’t publish that version. That would be cheating.
Overcoming Barriers in Cancer Clinical Trials: A Path Forward for Better Patient Care
April 29th 2024Clinical trials play a pivotal role in developing effective therapies, yet their integration is challenged by issues such as insufficient reimbursement structures, misaligned incentives, physician burnout, and a complex regulatory environment.
Read More
Gholam Analyzes Treatment Outcomes for Advanced HCC in Child-Pugh B Population
April 28th 2024During a live Community Case Forum event in partnership with the Tennessee Oncology Practice Society, Pierre Gholam, MD, examined the current state of treatment for patients with hepatocellular carcinoma, looking in particular at what data is available for those with Child-Pugh B and C status who have poorer outcomes and have limited data from prospective clinical trials.
Read More